Ambulatory blood pressure monitoring in clinical trials in adults and children

American Journal of Hypertension

Volumn 15, Issue 2 II, 2002, Pages

  Mansoor, George A ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive therapy; Clinical trials; Placebo effect

Indexed keywords

ANTIHYPERTENSIVE AGENT; PLACEBO;

ACCURACY; ADOLESCENT; ADULT; AMBULATORY MONITORING; BLOOD PRESSURE MONITORING; CALCULATION; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY; SAMPLING;

EID: 0036170839     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)02295-6     Document Type: Conference Paper

References (35)

1. The reproducibility of average ambulatory, home and clinic pressures
2. Observer bias in BP studies
3. Does placebo lower blood pressure?
4. White coat hypertension and related phenomena, a clinical approach
5. Responders and non-responders to antihypertensive treatment
6. Interchangeability of ambulatory and office blood pressure: Limitations of reproducibility and agreement
7. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials
8. Is it possible to file and approve a new antihypertensive without ambulatory blood pressure monitoring?
9. Analysis of ambulatory blood pressure monitoring: The problem of white-coat hypertension, responders and non-responders
10. The effect of antihypertensive treatment with dihydropyridine calcium antagonists on white-coat hypertension
11. Ambulatory monitoring of the blood pressure in multicenter clinical trials
12. White coat hypertension in children with elevated casual blood pressure
13. Diurnal blood pressure curve in children and adolescents
14. Double blind crossover versus parallel groups in hypertension
15. A practical approach to the evaluation of antihypertensive agents in infants and children: Study design and outcome measures
16. Ambulatory blood pressure and target organ involvement in hypertension
17. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild to moderate hypertension
18. Arterial distensibility and ambulatory blood pressure monitoring in hypertension
19. Abnormal renal function in isolated systolic hypertension correlation with ambulatory BP
20. Silent cerebrovascular disease in the elderly: Correlation with ambulatory pressure
21. Prognostic value of ambulatory blood pressure current evidence and clinical implications
22. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension
23. Influence of observers expectation on the placebo effect in blood pressure trials
24. How much of the placebo effect is really statistical regression?
25. Effect of placebo on 24-h non-invasive ambulatory blood pressure
26. Placebo does not lower ambulatory blood pressure
27. The placebo effect in ambulatory blood pressure monitoring
28. Repeated measurements of non-invasive ambulatory blood pressure: Distinction between reproducibility and the proper effect of placebo
29. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents
30. Ambulatory blood pressure monitoring in the evaluation of drug efficacy
31. Value of ambulatory blood pressure monitoring in clinical pharmacology
32. Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: Implications for studies on antihypertensive drugs
33. On the trough:peak ratio of drug effect in hypertension trials
34. Importance of various methods of blood pressure measurement in clinical trials
35. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects